ERBB2 and breast carcinoma: For instance, CEACAM6 interacts with HER2 in breast cancer cells, and CEACAM6 knockdown reduces the inhibitory effects of the anti‐HER2 antibody trastuzumab in trastuzumab‐sensitive cells [44].